학술논문

1149P Validation of a model combining clinicopathologic risk factors and a gene expression profile to identify primary melanoma patients who can safely forgo sentinel lymph node biopsy
Document Type
Abstract
Source
In Annals of Oncology September 2020 31 Supplement 4:S766-S766
Subject
Language
ISSN
0923-7534